and Tokyo Research Laboratories, 3-6-6 Asahimachi, Machida, Tokyo, Japan (Received for publication March 17, 1992) DNAtopoisomerases are enzymes that alter DNA conformation through a concerted breaking and rejoining of DNAstrands thereby controlling the topological state of DNA1}.Topoisomerase II has been shown to be the primary cellular target for a numberof clinically important antitumor agents with diverse and unrelated chemical structures2'3*. These antitumor drugs, referred as to "topoisomerase II poisons", trap the enzyme in an intermediary reversible complex with DNA,termed "cleavable complex" which prevents the final rejoining step of the reaction and results in increased DNAstrands breaks2?3). It is believed that the ability to form the cleavable complex with topoisomerase II is responsible for antitumor activity of these drugs.
In order to identify a specific new topoisomerase II poison, we have screened cultures of actinomycetes and fungi for their ability to induce topoisomerase II mediated DNAcleavage in vitro.
Wefound that the diterpeniod antitumor antibiotics terpentecin and clerocidin are potent inducers of DNA cleavage4), and have now isolated a novel compound with DNAcleavage activity, UCT4B, from the culture broth of actinomycetes which produces terpentecin. The producing organism was isolated from a soil collected in Yamaguchi Prefecture, Japan and was assigned to the genus Streptomyces. Fermentation was carried out at 28°C for 3 days under aeration of 400 liters/minute and agitation at lOOrpm in 200-liter tank fermenter containing 100 liters of culture mediumconsisting of sucrose 5%, KNO3 3%, KH2PO4 0.05%, MgSO4-7H2O 0.05%, Mg3(PO4)2 -8H2O 0.05%, pH 7.0. UCT4B accumulated in the culture medium. The culture filtrate was applied to a column of Diaion HP-20 (Mitsubishi Chemical Industries Limited).
The column was washed with deionized water-MeOH (1 : 1) and eluted with deionized water-MeOH (3:7).
The active eluate was concentrated and applied to a column ofDiaion HP-20SS. The column was washed with deionized water-MeOH(1 : 1) and the UCT4B containing fraction was eluted with deionized water-MeOH(3 : 7). The eluate was concentrated and extracted with ethyl acetate at pH 4.0. The active Topoisomerase II was purified from calf thymus as described previously4*. Stock solutions of drugs were dissolved in dimethyl sulfoxide at 50 mM, stored at -20°C and diluted in methanol containing 40% dimethyl sulfoxide before use. Reactions (20^1) containing 50 mMTris-HCl (pH 7.5), 100mM KC1, 10 mM MgCl2, l mMATP, 0.5mM dithiothreitol, 0.5 mMEDTA, 30/xg/ml of bovine serum albumin, 0.4/xg of pUL402 DNA,and DNAtopoisomerase II with or without drug were incubated at 37°C. After 30 minutes, reactions were terminated by the addition of 2^1 of solution containing 5% SDSand 2.5mg/ml of Proteinase K. Following an additional incubation at 37°C for 30 minutes, the sample were electrophoresed through a 1.2% agarose gel in 89mMTris-borate (pH 8.3), 2him EDTAbuffer containing 0.1% SDS. The concentration of topoisomerase II used in the DNAcleavage assay was at least 20 times higher than that required for full relaxation of pUL402DNAin the relaxation assay. After electrophoresis, gels were stained with ethidium bromide and photographed over UVillumination. Lane CCC, covalently closed circular (CCC)-DNA control; lane Linear, linear DNAcontrol.
organic layer was concentrated and further purified by silica gel chromatography (Licroprep Si60) using as an eluent. The active fractions were combined, and further purified by HPLC packed with ODS (YMC Pack ODS SH-363-5) to yield 100mg of UCT4B. UCT4Bwas obtained as a white powder and the physico-chemical properties are summarized in Table 1 . UCT4Bwas readily soluble in MeOH, acetone and DMSOand slightly soluble in H2O but hardly soluble in «-hexane. The molecular formula of UCT4B was determined as C20H28O7 by HREI-MS. The structure of UCT4B (Fig. 1) was assigned by XHand 13C NMRspectroscopic studies, which showed that UCT4Bis in an equilibrium state of tautomer similar to terpentecin and clerocidin5>6).
The structure determination and chemical properties of UCT4Bwill be reported in a separate paper7).
The topoisomerase II mediated DNAcleavage activity of UCT4Bwas studied in vitro using purified calf thymus topoisomerase II and plasmid DNA. (65°C) and salt (0.5m NaCl) treatment, which is strictly different from knowntopoisomerase II poisons such as ra-AMSAand VP-164).
UCT4Bexhibits an antimicrobial activity against Gram-positive bacteria and Klebsiella pneumoniae ( 
